Drug Development Health Data Pharmaceuticals 
Lloyd Price
OCTOBER 14, 2024
While the specific agenda may have varied, here are some of the main tracks and topics that were likely covered: Main Tracks: AI and Machine Learning: Discussions on the applications of AI and ML in drug discovery, medical imaging, and personalised medicine. Regulatory Landscape: Changes in healthcare regulations and policies.
Healthcare IT Today
JANUARY 7, 2025
As these implementations take hold, the emphasis will be on demonstrating measurable return on investment (ROI), with AI driving down administrative burdens, accelerating drug development, and significantly improving operational efficiency. What’s most exciting to me is AI’s potential impact on personalized medicine.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Digital Health Global
AUGUST 22, 2024
Spellman and Wortel are the most recent additions to Catawba Research’s team of scientific and regulatory advisors who support sponsors across a multitude of therapeutic areas and provide clinical development and regulatory strategy across North America, Europe and Asia.
Lloyd Price
MAY 16, 2023
The company has partnerships with organizations such as the Mayo Clinic, the University of California, San Francisco, and the Veterans Health Administration. Palantir's products are also being used by pharmaceutical companies, medical device manufacturers, and healthcare payers. Palantir's plans for healthcare are ambitious.
Lloyd Price
JANUARY 20, 2025
They initially focused on direct-to-consumer sales, offering insights into ancestry, health predispositions, and carrier status. They've leveraged this vast consumer dataset to establish partnerships with pharmaceutical companies for drug discovery and development. to predict future health risks.
Lloyd Price
MAY 18, 2021
The COVID-19 pandemic has prompted widespread use of real-world data (1). Desperate for medical insights without delay, researchers, pharmaceutical companies and government agencies turned to health information captured through real-world data sources. The world’s most valuable resource is no longer oil, but data.
Lloyd Price
DECEMBER 11, 2023
Transforming healthcare A report from the London School of Economics, The Role of Virtual Health Care and the Pharmaceutical Sector in Improving Population Health , published in 2021, forecast that the pharmaceutical industry would be a core player in all aspects from population health management to preventive and therapeutic care.
Expert insights. Personalized for you.
57 
Let's personalize your content